While there are no approved herpes vaccines available in 2023, the U.S. government recently funded research being conducted at the University of Pittsburgh School of Medicine.
The National Institute of Allergy and Infectious Diseases (NIAID) confirmed on November 1, 2023, that it had awarded $504,170 to a research project led by Neal A. DeLuca.
The ongoing theme of this innovative program is to study the virus-cell interactions that affect Herpes simplex virus (HSV) gene expression.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
